Please assess the completion status of the following clinical trial:

Trial Title: A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Intubated, on mechanical ventilation, and anticipated to remain on mechanical ventilation for 2 days after enrollment into the study~* Receiving enteral feeding and assessed to have developed EFI, as defined by a GRV measurement ≥250 mL within the 24 hours before randomization~Exclusion Criteria:~* History of diabetic or idiopathic gastroparesis~* Screening blood glucose \>15 mmol/L (270 mg/dL) while receiving insulin~* Impaired renal function, as defined by estimated glomerular filtration rate (eGFR) \<30 mL/min, as determined by the Cockcroft-Gault formula -Bilirubin concentration in blood \>2 times the upper limit of normal~* ALT or AST \>3 times upper limit of normal~* Alkaline phosphatase \>2 times upper limit of normal~* Contraindication to enteral feeding~* Opioid or other drug overdose as the primary reason for admission to Intensive Care Unit (ICU)~* Receipt of a drug that can be used as a gastric prokinetic agent~* Receipt of agents known to directly influence the 5 HT4/acetylcholine prokinetic mechanism

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- TD-8954 (Type: EXPERIMENTAL): TD-8954 single infusion for 1 hour and 4 injections of saline every 6 hours
- Metoclopramide (Type: ACTIVE_COMPARATOR): Metoclopramide 4 doses every 6 hours for 24 hours and 1 hour infusion of saline

Based on this trial design, predict the completion outcome and termination type (if applicable).